ESH Video

#ESHMPN2022 - ONE WEEK LEFT TO SUBMIT YOUR ABSTRACT & SCHOLARSHIP

February 14, 2022
 

9th Translational Research Conference

MYELOPROLIFERATIVE NEOPLASMS

 

May 13-15, 2022

Budapest, Hungary

#ESHMPN2022

   

DO NOT MISS THE OPPORTUNITY!
ONLY ONE WEEK LEFT TO SUBMIT YOUR ABSTRACTS!
DEADLINE: FEBRUARY 20th, 2022 (23:59 CET)


Abstracts are eligible to be selected for an oral or a poster presentation.

 

ESH SCHOLARSHIP FUND

  This Call for Applications is made thanks to a funding support from:




  The present  Call for Applications may be of interest to you if you are:

DEADLINE FOR APPLICATIONS:
FEBRUARY 20th, 2022



The ESH Scholarship Fund is a multi-sponsored project designed to support access to new biological and clinical data in the context of lifelong learning in Haematology.
- ESH independently ensures all scientific peer review and selection procedures.
- ESH is also independently responsible for all administrative aspects of the Fund.  



ELIGIBILITY CRITERIA:
- You are eligible to apply if you are fully-trained, with a maximum of six-years professional experience since your first junior faculty appointment
- or still in-training

SCHOLARSHIPS WILL COVER:
- Registration fee (which includes conference materials, the Welcome Get-together, coffee breaks and luncheons during the conference)
- A travel grant to a maximum of 500 € (paid upon presentation of corresponding receipts).

TO APPLY: 
please download and complete the application form and send it with the following documents to maude.brunet-lecomte@univ-paris-diderot.fr:
- personal information
- a cover letter
- an official letter signed by the head of your department or laboratory certifying your in-training or early career status
- your curriculum vitae and photo
- an abstract (see submission link below)
- your list of publications (if possible)

POST-CONFERENCE REPORT:
Scholarship recipients will be required to submit a brief report on the meeting before June 13th, 2022.


Registration is open!
Join us in Budapest, Hungary




About the Conference:

New insights into the molecular pathogenesis, classification, and management of patients with Myeloproliferative Neoplasms (MPN) have arisen at increasing pace during the past years. This International Conference brings together scientists and clinicians to present and discuss new data on the cellular and molecular biology of these disorders as well as their diagnosis and treatment.

The field of MPN research is rapidly expanding and consequently treatment options are changing. Clinical and laboratory investigators involved in the care of MPN patients or in research on the biology of these diseases will profit from hearing international leaders present the newest biological, clinical and therapeutic developments in the field.

The format of the scientific programme is deliberately designed to be conducive to close scientific interaction between speakers and registered participants from all over the world.

CONFERENCE MAIN TOPICS:
• Molecular pathogenesis of MPNs
• Novel MPN therapeutics
• MPN initiation and clonal evolution
• Murine MPN models and pathogenesis/therapeutic studies
• Molecular pathogenesis and therapy of MPN progression and leukaemic transformation
• Recent advances in therapeutics
• Molecular pathogenesis of MPN





LEARNING OBJECTIVES
Upon completion of this CME activity, participants should be able:
• To understand the newest discoveries on the molecular pathogenesis of MPN
• To appreciate recent changes in treatment recommendations for MPN patients including
the evolving landscape of approved therapies
• To gain insight into ongoing clinical trials investigating novel agents for MPN treatment
• To increase knowledge about cellular and animal models of MPN and their use for drug screening

THE PROGRAMME WILL INCLUDE:
 Keynote Lectures - Plenary Sessions - Simultaneous Meet the Expert Sessions - Mentored Poster Walks - Short Oral Communications- Ample time for in-depth discussion


SCIENTIFIC PROGRAMME

MEET THE FACULTY

MORE INFORMATION


With the support of*:





Level 1 Conference Partner
*******



Level 2 Conference Partners
*******

*
ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.